/

Empresas

Pe

No verificado

PeproMene Bio, Inc.

Sobre qué escribimos

BiologíaEventosFarmacéuticaMedio Ambiente/EcologíaSanidad

3 Comunicados de prensa

Ver todos los comunicados de prensa

Press Release cover image

28/05/2026

Salud

Fitness

Ferias y Congresos

Eventos

Medicina - Varios

Medio Ambiente/Ecología

Agricultura

PeproMene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas, Including After Prior CD19 CAR T-Cell Failure

Fuente

PeproMene Bio, Inc.

Editor

1.00

0

20/05/2025

Farmacéutica

Sanidad

Biología

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation (IFLI) Announce The First Follicular Lymphoma (FL) Patient Treated with BAFF-R Targeting CAR-T Cells (PMB-CT01) Achieves a Complete Response

Fuente

PeproMene Bio, Inc.

Editor

1.00

0

Press Release cover image

07/08/2024

Farmacéutica

Sanidad

Biología

PeproMene Bio announced study demonstrating strong polyfunctionality of novel chimeric antigen receptor (CAR) T cells

Fuente

PeproMene Bio, Inc.

Editor

1.00

0

Seguidores

0

Compatibilidad

0